These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31760675)

  • 21. Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.
    Mohy-Eldeen ZM; Ahmad AR; Mahran HH; Saad K
    Turk J Pediatr; 2020; 62(6):962-969. PubMed ID: 33372434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy of Intravenous Immunoglobulin in Guillain-Barré Syndrome: The Experience of a Tertiary Medical Center.
    Shalem D; Shemer A; Shovman O; Shoenfeld Y; Kivity S
    Isr Med Assoc J; 2018 Dec; 20(12):754-760. PubMed ID: 30550005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.
    Charra B; Hachimi A; Benslama A; Motaouakkil S
    Pan Afr Med J; 2014; 18():35. PubMed ID: 25368724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IVIG treatment and prognosis in Guillain-Barré syndrome.
    van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial.
    Haridy NA; Shehab MM; Khedr EM
    Restor Neurol Neurosci; 2023; 41(5-6):203-217. PubMed ID: 38217554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of Guillain-Barré syndrome (GBS) in China: a 10-year comprehensive overview.
    Song Y; Zheng X; Fang Y; Liu S; Liu K; Zhu J; Wu X
    Rev Neurosci; 2023 Dec; 34(8):869-897. PubMed ID: 37145885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome: epidemiology, pathophysiology and management.
    Kuwabara S
    Drugs; 2004; 64(6):597-610. PubMed ID: 15018590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barre syndrome: a clinical study in King Chulalongkorn Memorial Hospital.
    Areeyapinan P; Phanthumchinda K
    J Med Assoc Thai; 2010 Oct; 93(10):1150-5. PubMed ID: 20973317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
    Jacobs BC; van den Berg B; Verboon C; Chavada G; Cornblath DR; Gorson KC; Harbo T; Hartung HP; Hughes RAC; Kusunoki S; van Doorn PA; Willison HJ;
    J Peripher Nerv Syst; 2017 Jun; 22(2):68-76. PubMed ID: 28406555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novel Therapeutic Interventions in Guillain-Barré Syndrome: Review and Future Perspective].
    Misawa S
    Brain Nerve; 2015 Nov; 67(11):1421-8. PubMed ID: 26560957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain Barre Syndrome in the elderly: Experience from a tertiary-care hospital in India.
    Nagappa M; Rahul W; Sinha S; Bindu PS; Mathuranath PS; Rao S; Periyavan S; Umamaheshwara Rao GS; Taly AB
    J Clin Neurosci; 2017 Dec; 46():45-49. PubMed ID: 28890042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Profile and Outcome of Guillain-Barre Syndrome in Pediatric Patients Admitted to a Tertiary Care Centre: A Retrospective Study.
    Rangan RS; Tullu MS; Deshmukh CT; Mondkar SA; Agrawal M
    Neurol India; 2021; 69(1):81-84. PubMed ID: 33642275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of Guillain-Barré syndrome.
    Liu S; Dong C; Ubogu EE
    Hum Vaccin Immunother; 2018; 14(11):2568-2579. PubMed ID: 29953326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.
    Shahrizaila N; Yuki N
    Expert Opin Pharmacother; 2011 Jul; 12(10):1551-60. PubMed ID: 21473704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
    Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
    Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
    Blum S; Reddel S; Spies J; McCombe P
    J Peripher Nerv Syst; 2013 Dec; 18(4):316-20. PubMed ID: 24172315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features.
    França MC; Deus-Silva L; de Castro R; Garibaldi SG; Pfeilsticker BH; Nucci A; Marques JF
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):772-5. PubMed ID: 16258654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in management of Guillain-Barré syndrome.
    Doets AY; Jacobs BC; van Doorn PA
    Curr Opin Neurol; 2018 Oct; 31(5):541-550. PubMed ID: 30074496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.